- Home
- CDE vs RVTY Comparison
CDE vs RVTY Comparison
Compare CDE & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CDE | RVTY |
|---|---|---|
| Founded | 1928 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 11.8B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CDE | RVTY |
|---|---|---|
| Price | $22.28 | $95.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 15 |
| Target Price | $21.50 | ★ $113.00 |
| AVG Volume (30 Days) | ★ 29.7M | 1.7M |
| Earning Date | 02-18-2026 | 02-02-2026 |
| Dividend Yield | N/A | ★ 0.29% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.74 | ★ 2.07 |
| Revenue | $1,700,723,000.00 | ★ $2,856,051,000.00 |
| Revenue This Year | $96.49 | $6.06 |
| Revenue Next Year | $43.51 | $5.15 |
| P/E Ratio | ★ $28.37 | $46.20 |
| Revenue Growth | ★ 68.28 | 3.67 |
| 52 Week Low | $4.58 | $81.36 |
| 52 Week High | $27.77 | $120.39 |
Technical Indicators
Market Signals| Indicator | CDE | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 49.37 | 38.74 |
| Support Level | $20.91 | $93.70 |
| Resistance Level | $23.71 | $106.55 |
| Average True Range (ATR) | 1.75 | 4.33 |
| MACD | -0.30 | -1.62 |
| Stochastic Oscillator | 30.97 | 15.05 |
Price Performance
Historical ComparisonAbout CDE Coeur Mining Inc.
Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada, and Mexico.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.